Plus, Curaleaf wants a TSX listing, too.
Plus, Cookies gets sued again, and Curaleaf wants to buy Cronos? Maybe?
It'll be a dogfight for the future of New York's legal cannabis market. Plus, a big new study into the public health impacts of legalization in Canada, and more.
Plus, New York's regulatory woes, Glass House fires back, and more.
Plus, Acreage Holdings gets walloped, a drug for cannabis addiction, and much more.
Introducing the Cultivated Sunday Read.
Plus, Pax launches gummies, Alabama's obsessed with peaches, and more.
The letter includes details of the severance package workers received.
Plus, notes on the short and long-term vision of this newsletter, and how to make capitalism work with, not against, journalism.
Plus, an exclusive survey on New York cannabis consumers, Adjusted EBITDA, and the perils of childproof packaging.
Plus, Wall Street retrenches, New York's new rules, and mental health.
Plus, Hochul's new budget has teeth, the chicken wing/roach problem, and more.
